Skip to main content
Stephen Baylin, MD, Endocrinology, Baltimore, MD

StephenBruceBaylinMD

Endocrinology • Baltimore, MD

Professor, Oncology, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Baylin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Baylin's full profile

Already have an account?

  • Office

    1830 E Monument St # Med
    Johns Hopkins Hospital
    Baltimore, MD 21287

Education & Training

  • Duke University School of Medicine
    Duke University School of MedicineClass of 1968

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1971 - 2014

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1981

Publications & Presentations

PubMed

Abstracts/Posters

  • DNA Methyltransferase Inhibitors Promote Homologous Recombination Deficiency through Induction of Immune Signaling, Sensitizing Acute Myeloid Leukemia Cells to PARP In...
    Stephen Baylin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Coriell Institute for Medical Research, Van Andel Institute Awarded Estimated $12.4 Million SPORE Grant from National Cancer Institute
    Coriell Institute for Medical Research, Van Andel Institute Awarded Estimated $12.4 Million SPORE Grant from National Cancer InstituteSeptember 22nd, 2021
  • Remembering Mark Smith, Cancer Researchers Receive 2020 AAAS Fellow Distinction, and More
    Remembering Mark Smith, Cancer Researchers Receive 2020 AAAS Fellow Distinction, and MoreJanuary 1st, 2021
  • Combination of Two Drugs Disrupts Cancer Cells' Ability to Survive DNA Damage, Study Finds
    Combination of Two Drugs Disrupts Cancer Cells' Ability to Survive DNA Damage, Study FindsOctober 15th, 2019
  • Join now to see all

Grant Support

  • DNA Methyltrasferase Gene Expression In Colon CancerNational Institute Of Environmental Health Sciences2009–2012
  • Development Research ProgramNational Cancer Institute2009–2012
  • Career Development ProgramNational Cancer Institute2009–2012
  • CA: Administrative CoreNational Cancer Institute2009–2012
  • Spore In Lung CancerNational Cancer Institute1996–2012
  • Methylation Of The Calcitonin Gene In Human TumorsNational Cancer Institute1986–2012
  • The Usc-Jhu Cancer Epigenome Characterization CenterNational Cancer Institute2009–2011
  • Program LeadershipNational Cancer Institute2006–2010
  • MicroarrayNational Cancer Institute2006–2010
  • CRCNational Cancer Institute2006–2010
  • The Environment And Epigenetic Gene Silencing In CancerNational Institute Of Environmental Health Sciences2006–2009
  • Cancer Genome Characterization Center At Johns HopkinsNational Cancer Institute2006–2009
  • Developmental Pathways, Cancer, And DNA HypermethylationNational Cancer Institute2005–2009
  • DNA Methyltransferase Gene Expression In Colon CancerNational Institute Of Environmental Health Sciences2002–2008
  • Regional Oncology Research CenterNational Cancer Institute2007
  • Lung Cancer--Developmental Research ProgramNational Cancer Institute1996–2002
  • Lung Cancer--Career DevelopmentNational Cancer Institute1996–2002
  • DNA Methylation/Neuroendocrine Differentiation--Marking Early State Lung CancerNational Cancer Institute1996–2002
  • DNA Methyltransferase Gene Expression In Colon CancerNational Cancer Institute1991–2000
  • Screening Cancer Genomes For CPG Island HypermethylationNational Cancer Institute1997–1999
  • Special Project On Research Excellence--Lung CancerNational Cancer Institute1993–1995
  • Tumor Progression In Small Cell Lung CancerNational Cancer Institute1988–1994
  • Regulation Of Tumor Progression In Small Cell Lung CanceNational Cancer Institute1993
  • Specialized Program Of Research Excellence/Lung CancerNational Cancer Institute1992
  • Regulating Tumor Progression In Small Cell Lung CancerNational Cancer Institute1991–1992
  • Neuroendocrine Differentiation In Human TumorsNational Cancer Institute1985–1986
  • DFMO In The Treatment Of Human Small Cell Lung CancerNational Cancer Institute1985

Dr. Stephen Baylin, Dr. Stephen Baylin, MD, Dr. S Baylin, Dr. Stephen Bruce Baylin